148 related articles for article (PubMed ID: 25754282)
1. Comparison of chromogranin A (CgA) levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males.
Glinicki P; Jeske W; Kapuścińska R; Zgliczyński W
Endokrynol Pol; 2015; 66(1):53-6. PubMed ID: 25754282
[TBL] [Abstract][Full Text] [Related]
2. The differences in chromogranin A (CgA) concentrations measured in serum and in plasma by IRMA and ELISA methods.
Glinicki P; Kapuścińska R; Jeske W
Endokrynol Pol; 2010; 61(4):346-50. PubMed ID: 20806177
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A (CgA) in adrenal tumours.
Glinicki P; Jeske W; Bednarek-Papierska L; Kasperlik-Załuska A; Rosłonowska E; Gietka-Czernel M; Zgliczyński W
Endokrynol Pol; 2013; 64(5):358-62. PubMed ID: 24186592
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of CisBio ELISA for Chromogranin A Measurement.
Lim M; Erdman P; Cho S; Mathew A; Fleisher M; Thoren KL
J Appl Lab Med; 2019 Jul; 4(1):11-18. PubMed ID: 31639703
[TBL] [Abstract][Full Text] [Related]
5. High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma.
Cotesta D; Caliumi C; Alò P; Petramala L; Reale MG; Masciangelo R; Signore A; Cianci R; D'Erasmo E; Letizia C
Tumori; 2005; 91(1):53-8. PubMed ID: 15850005
[TBL] [Abstract][Full Text] [Related]
6. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan.
Giovanella L; Squin N; Ghelfo A; Ceriani L
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):344-7. PubMed ID: 17043632
[TBL] [Abstract][Full Text] [Related]
8. Preanalytical factors of importance for measurement of Chromogranin A.
Pedersen L; Nybo M
Clin Chim Acta; 2014 Sep; 436():41-4. PubMed ID: 24804936
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A as serum marker of pituitary adenomas.
Gussi IL; Young J; Baudin E; Bidart JM; Chanson P
Clin Endocrinol (Oxf); 2003 Nov; 59(5):644-8. PubMed ID: 14616890
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.
Qiao XW; Qiu L; Chen YJ; Meng CT; Sun Z; Bai CM; Zhao DC; Zhang TP; Zhao YP; Song YL; Wang YH; Chen J; Lu CM
BMC Endocr Disord; 2014 Aug; 14():64. PubMed ID: 25099181
[TBL] [Abstract][Full Text] [Related]
11. Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.
Monaghan PJ; Lamarca A; Valle JW; Hubner RA; Mansoor W; Trainer PJ; Darby D
Clin Endocrinol (Oxf); 2016 Mar; 84(3):348-52. PubMed ID: 26608723
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies.
Molina R; Alvarez E; Aniel-Quiroga A; Borque M; Candás B; Leon A; Poyatos RM; Gelabert M
Tumour Biol; 2011 Feb; 32(1):13-22. PubMed ID: 20730520
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma.
Bílek R; Šafařík L; Ciprová V; Vlcek P; Lisá L
Physiol Res; 2008; 57 Suppl 1():S171-S179. PubMed ID: 18271679
[TBL] [Abstract][Full Text] [Related]
14. [Chromogranin A (CgA) - the influence of various factors in vivo and in vitro, and existing disorders on it's concentration in blood].
Glinicki P; Jeske W
Endokrynol Pol; 2011; 62 Suppl 1():25-8. PubMed ID: 22125107
[TBL] [Abstract][Full Text] [Related]
15. An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination.
Verderio P; Dittadi R; Marubini E; Pizzamiglio S; Gion M; De Apollonia L; Paradiso A;
Clin Chem Lab Med; 2007; 45(9):1244-50. PubMed ID: 17663633
[TBL] [Abstract][Full Text] [Related]
16. Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumors.
Bernini G; Moretti A; Fontana V; Orlandini C; Miccoli P; Berti P; Basolo F; Faviana P; Bardini M; Salvetti A
Eur J Endocrinol; 2004 Aug; 151(2):215-22. PubMed ID: 15296477
[TBL] [Abstract][Full Text] [Related]
17. [The sympathetic nervous system activity estimated on serum concentration of chromogranin A in patients with the chronic heart failure].
Rubinsztajn R
Pol Arch Med Wewn; 2001 Mar; 105(3):217-24. PubMed ID: 11680266
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy inpatients with adrenal incidentalomas.
Giovanella L; Ceriani L; Balerna M; Keller F; Taborelli M; Marone C; Ferone D
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):84-88. PubMed ID: 17538521
[TBL] [Abstract][Full Text] [Related]
19. [Chromogranin A (CgA) - characteristic of the currently available laboratory methods and conditions which can influence the results].
Glinicki P; Jeske W
Endokrynol Pol; 2009; 60(5):415-9. PubMed ID: 19885814
[TBL] [Abstract][Full Text] [Related]
20. Plasma and tissue chromogranin in patients with adrenocortical adenomas.
Bernini GP; Moretti A; Borgioli M; Bardini M; Miccoli P; Berti P; Basolo F; Faviana P; Birindelli R; Salvetti A
J Endocrinol Invest; 2004 Oct; 27(9):821-5. PubMed ID: 15648545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
